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A report on the 6th EMBL Transcription Meeting,
Heidelberg, Germany, 28 August-1 September 2004.
There were many exciting talks presented at the recent
EMBL Transcription meeting in Heidelberg that reported
recent insights into the role of chromatin-modifying protein
complexes in transcriptional regulation, and four captured
our interest especially. They all concern work on a ribonucleo-
protein complex that has a defined biological role - namely
to regulate dosage compensation in flies. This dosage com-
pensation complex (DCC; also referred to as the MSL
complex or the ‘compensasome’) consists of the histone
acetyltransferase encoded by males-absent-on-the-first
(mof), the male-specific-lethal-encoded proteins MSL1,
MSL2 and MSL3, the Maleless (MLE) helicase and two non-
coding RNAs, RNA-on-the-X (roX) 1 and roX2. In addition,
it has been suggested that the DCC associates with the JIL1
protein kinase.
According to the prevalent model, the DCC is necessary for
upregulating gene expression from the single male X chromo-
some precisely twofold, thus ensuring that male and female
flies produce the same amount of X-linked gene products.
The DCC, which does not form in females, is believed to facil-
itate transcription from the hyperactive X. This occurs at
least in part through acetylation of histone H4 lysine 16 of the
X chromosome, and this acetylation is believed to be cat-
alyzed by the MOF histone acetyltransferase subunit.
Immunostaining of the polytene chromosomes has revealed a
strong and specific association between the DCC and the
male X chromosome; indeed, the DCC ‘paints’ the X chromo-
some, but not the autosomes, in its entirety.
How does this peculiar localization of the DCC come about?
Mutant flies lacking certain subunits of the DCC (but retain-
ing the MSL1 and MSL2 core components) show reduced
binding to the male X chromosome. In fact, instead of a
chromosome-wide association, DCC binding in the mutants
is restricted to 30-55 sites. This and other findings have led
to a model whereby the DCC first binds to specialized ‘entry
sites’ on the X from where it ‘spreads’ in an as yet undefined
manner to cover the entire chromosome. This model has
been around for several years but has now suddenly come
under fire from two directions. 
Delphine Fagegaltier from Bruce Baker’s laboratory (Stan-
ford University, USA) reported experiments showing that
many large fragments derived from the X chromosome, even
if they do not contain one of the reported entry sites, attract
the DCC when translocated into an autosome. This strongly
argues that the reported entry sites are not strictly required
for DCC binding to be seeded. Furthermore, DCC was never
observed to spread across the X chromosome/autosome
boundary on these chromosomes. Similar results have recently
been obtained in the laboratory of M. Kuroda (Oh et al., Curr
Biol 2004, 14:481-487). 
Results from experiments using fluorescence recovery after
photobleaching (FRAP) and aimed at determining the
dynamic nature of X-chromosome-bound DCC were
reported by Peter Becker (University of Munich, Germany).
The DCC turns out to be surprisingly immobile: throughout
the course of the experiment, fluorescence in the bleached
region was not recovered, demonstrating that the DCC is
remarkably static and, once bound to the X, does not seem to
want to let go. This property does not support the idea of a
constant redistribution of MSL proteins that would seem to
be a prerequisite for a rapid spreading mechanism.
These results are clearly incompatible with the existing
entry-site/spreading model. But if there are no special entry
sites on the X chromosome, why is DCC binding restricted to
the X, and how does it happen that the X gets covered in its
entirety? Fagegaltier suggested that ‘entry sites’ in factrepresent high-affinity binding sites for the DCC, which the
complex can bind even when it is missing certain subunits.
In addition, there could be many binding sites of lower affin-
ity throughout the remainder of the chromosome. This sce-
nario would be compatible both with previous work and the
new findings of Fagegaltier and Becker. Only very few
binding sites for the DCC have been characterized to date
but no common feature has been identified, so the nature of
DCC-binding sites remains mysterious.
The impact of the DCC on chromatin structure is also under
investigation. John Tamkun (University of California, Santa
Cruz, USA) and collaborators had previously reported that
when the chromatin-remodeling ATPase known as IMITA-
TION SWITCH (ISWI) is knocked out in flies, the architec-
ture of the male X chromosome is drastically altered.
Interestingly, this abnormally decompacted chromosome is
rescued by disruption of the DCC. Moreover, the X chromo-
somes also decondense in iswi mutant females upon ectopic
expression of MSL2, which artificially forces DCC formation.
Biochemical analyses further support the notion that the
DCC functionally antagonizes ISWI, at least in part, through
acetylation of lysine 16 of histone H4. 
At the meeting Tamkun presented new findings on the chro-
matin composition of the male X chromosome in iswi
mutants: immunostaining has revealed that the chromatin
of the X chromosome, but not the autosomes, lacks histone
H1, suggesting that an ISWI-containing remodeling factor is
involved in the assembly of H1-containing chromatin. He
proposed that the reason only the X chromosome lacks H1 is
that the small maternal contribution of ISWI in these flies is
sufficient to ensure normal autosomal architecture, as the
comparatively low levels of H4 lysine 16 acetylation on auto-
somes would not inhibit ISWI function. Consistent with this
idea, removal of both maternal and zygotic sources of ISWI
activity prevents histone H1 from loading onto all chromo-
somes. These results uncover a possible new role for the
ISWI ATPase in the stabilization of higher-order chromatin
structures by promoting genome-wide H1 incorporation.
The precise relationship between dosage compensation and
H1 incorporation remains to be established, however.
Different organisms achieve dosage compensation in differ-
ent ways. Accordingly, one might expect the DCC to be a
molecular machine that operates in flies only. In mammals,
gene expression from the single X chromosome in males is
not upregulated. Instead, one of the two X chromosomes in
females is inactivated to achieve the same effect - equaliza-
tion of X-linked gene products in the two sexes. Given the
vastly different mechanisms of dosage compensation in flies
and mammals, one might not expect to find subunits of the
Drosophila DCC conserved in humans. But Asifa Akhtar
(European Molecular Biology Laboratory, Heidelberg,
Germany) showed that most subunits of the DCC do indeed
have homologs in the human proteome and that some of
these human proteins interact in vivo. Human MOF (hMOF)
is not able to replace its counterpart in flies, however: it is
unable to rescue mof mutants and shows no localization to
the X chromosome when expressed in flies. Instead, hMOF
binds equally well to all fly chromosomes. This suggests that
properties of Drosophila MOF that are essential for dosage
compensation have not been conserved, and raises the possi-
bility that human MOF has evolved new functions. Indeed,
when Akhtar depleted hMOF from a human cell line by RNA
interference (RNAi) using small interfering RNA (siRNA)
she observed defects in the cell cycle and in nuclear mor-
phology. The molecular changes underlying these pheno-
types remain to be established. Understanding the function
of DCC-related complexes in flies and mammals holds many
challenges for the future and promises to teach us how evo-
lution has adapted this successful molecular machine to
perform different functions in each setting.
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